Trial Profile
A randomized crossover study to evaluate the circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary) ; Travoprost
- Indications Low tension glaucoma
- Focus Therapeutic Use
- 13 Oct 2015 New trial record